{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T08:08:59Z","timestamp":1750406939194},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T00:00:00Z","timestamp":1403049600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1038\/npp.2014.104","type":"journal-article","created":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T07:02:54Z","timestamp":1403074974000},"page":"2707-2708","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u2018Acute Shift in Glutamate-Concentrations Following Experimentally Induced Panic with Cholecystokinin-Tetrapeptide\u2014A 3T-MRS Study in Healthy Subjects\u2019\u2014A Reply to the Letter to the Editor"],"prefix":"10.1038","volume":"39","author":[{"given":"Peter","family":"Zwanzger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Yassouridis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Pfleiderer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,18]]},"reference":[{"key":"BFnpp2014104_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0893-133X(98)00074-8","volume":"20","author":"M Depot","year":"1998","unstructured":"Depot M, Caill\u00e9 G, Mukherjee J, Katzman MA, Cadieux A, Bradwejn J (1998). Acute and chronic role of 5-HT3 neuronal system on behavioral and neuroendocrine changes induced by intravenous cholecystokinin tetrapeptide administration in humans. Neuropsychopharmacology 20: 177\u2013187.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2014104_CR2","first-page":"663","volume":"27","author":"A Flint","year":"2002","unstructured":"Flint A, Bradwejn J, Vaccarino F, Gutkowska J, Palmour R, Koszycki D (2002). Aging and panicogenic response to cholecystokinin tetrapeptide: an examination of the cholecystokinin system. Neuropsychopharmacology 27: 663\u2013671.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2014104_CR3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0006-3223(97)00536-2","volume":"44","author":"JM Le Melledo","year":"1998","unstructured":"Le Melledo JM, Bradwejn J, Koszycki D, Bichet DG, Bellavance F (1998). The role of the beta-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptoms. Biol Psychiatry 44: 364\u2013366.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2014104_CR4","doi-asserted-by":"crossref","unstructured":"Maddock RJ (2014). Glutamate changes in anterior cingulate cortex following CCK-4 infusion. Neuropsychopharmacology (this issue).","DOI":"10.1038\/npp.2014.93"},{"key":"BFnpp2014104_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.peptides.2012.02.014","volume":"35","author":"D Koszycki","year":"2012","unstructured":"Koszycki D, Prichard Z, Fiocco AJ, Shlik J, Kennedy JL, Bradwejn J (2012). CCK-B receptor gene and response to cholecystokinin-tetrapeptide in healthy volunteers. Peptides 35: 9\u201313.","journal-title":"Peptides"},{"key":"BFnpp2014104_CR6","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/npp.2013.61","volume":"38","author":"P Zwanzger","year":"2013","unstructured":"Zwanzger P, Zavorotnyy M, Gencheva E, Diemer J, Kugel H, Heindel W et al (2013). Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide\u2014a 3T-MRS study in healthy subjects. Neuropsychopharmacology 38: 1648\u20131654.","journal-title":"Neuropsychopharmacology"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2014104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2014104","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2014104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:47:51Z","timestamp":1684453671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2014104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,18]]},"references-count":6,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["BFnpp2014104"],"URL":"https:\/\/doi.org\/10.1038\/npp.2014.104","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,18]]},"assertion":[{"value":"18 June 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}